Literature DB >> 21191823

Moyamoya disease and surgical intervention.

Jay W Rhee1, Suresh N Magge.   

Abstract

Stroke is an increasingly recognized cause of morbidity in the pediatric population. The incidence of ischemic stroke is 1.2 per 100,000 children. There are many known etiologies of childhood cerebral ischemia but moyamoya is one of the only ischemic conditions of childhood that can be effectively treated with surgery. Moyamoya disease is by definition idiopathic, whereas moyamoya syndrome refers to a similar disease course in conjunction with a known predisposing condition. The clinical manifestations and disease progression are similar. Furthermore, surgical treatment has been shown to be efficacious and safe in the treatment of moyamoya.

Entities:  

Mesh:

Year:  2011        PMID: 21191823     DOI: 10.1007/s11910-010-0173-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  67 in total

Review 1.  Moyamoya disease.

Authors:  M Fukui; S Kono; K Sueishi; K Ikezaki
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

2.  Moyamoya disease and syndrome.

Authors:  H J Hoffman
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

3.  Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

Authors:  K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

4.  Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease).

Authors:  Y Hosoda; E Ikeda; S Hirose
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

5.  Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications.

Authors:  K Houkin; T Ishikawa; T Yoshimoto; H Abe
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

6.  Anesthetic management of children with moyamoya disease.

Authors:  M Kansha; K Irita; S Takahashi; T Matsushima
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

Review 7.  Revascularisation surgery for paediatric moyamoya: a review of the literature.

Authors:  Lai-Wah Eva Fung; Dominic Thompson; Vijeya Ganesan
Journal:  Childs Nerv Syst       Date:  2005-02-05       Impact factor: 1.475

8.  Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease.

Authors:  S A Hosain; J T Hughes; S L Forem; J Wisoff; I Fish
Journal:  J Child Neurol       Date:  1994-10       Impact factor: 1.987

Review 9.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

10.  A novel susceptibility locus for moyamoya disease on chromosome 8q23.

Authors:  Kaoru Sakurai; Yasue Horiuchi; Hidetoshi Ikeda; Kiyonobu Ikezaki; Takashi Yoshimoto; Masashi Fukui; Tadao Arinami
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.